OXO-Chemie’s drug Macrokine (WF 10) is a macrophage-regulating drug, which regulates inflammation and
has direct effects on the body’s macrophages, immune cells that fight bacterial and fungal infections and “tell”
lymphocytes, such as T cells, to fight off viral infections. The drug was tested in Phase III clinical trials for
HIV infection and Phase II clinical trials had begun for non-responders to IFN/ribavirin Therapy (2002) (
www.oxochemie.com).